News
Important Only
EMERGING MARKETS-LatAm assets extend slide as politics test rate-fueled optimism
Currencies down 0.7%, stocks fall 0.4%Brazil stocks rebound after dropRegional politics in spotlightBy Niket Nishant Dec 8 (Reuters) - Latin American currencies extended their slide on Monday as investors fretted over political uncertainty and looked ahead to central bank decisions, while Brazil...Reuters
Mon, Dec 8
CANADA STOCKS-TSX muted as investors brace for important central bank decisions
By Avinash P Dec 8 (Reuters) - Canada's main stock index was subdued on Monday, with technology shares leading gains, ahead of crucial monetary policy decisions in the U.S. and Canada later this week.Toronto's S&P/TSX Composite Index .GSPTSE was flat at 31,296.10 points by 10:00 a.m....Reuters
Mon, Dec 8
Wave Life surges after positive data for its weight-loss drug
Shares of drug developer Wave Life Sciences WVE.O more than double to $15.4 premarketWVE says its experimental obesity drug helped cut deep belly fat and boost muscle mass in an early-stage studyThe drug, WVE-007, was tested in adults with an average starting body mass index of about 32Three months ...Reuters
Mon, Dec 8
Mirum to buy Bluejay for up to $820 million in bet on liver-disease drug
By Kamal ChoudhuryDec 8 (Reuters) - Mirum Pharmaceuticals MIRM.O said on Monday it will buy Bluejay Therapeutics in a deal worth up to $820 million, adding a late-stage experimental drug for a severe liver disease.The deal will give the company worldwide rights to brelovitug, a monoclonal antibody ...Reuters
Mon, Dec 8
Ocular jumps on plans to fast-track FDA filing for eye disease drug
Shares of Ocular Therapeutix OCUL.O rise 27% to $15.91OCUL plans to submit a marketing application for its eye disease drug, Axpaxli, to treat wet age-related macular degeneration after one-year data from its ongoing late-stage trial, expected in the first quarter of 2026Wet AMD is a leading cause o...Reuters
Mon, Dec 8
Dyne Therapeutics rises after positive data for its muscle wasting drug
Shares of drug developer Dyne Therapeutics DYN.O rise 16.2% to $23.62DYN's experimental drug zeleciment rostudirsen for the treatment of Duchenne muscular dystrophy (DMD) met the main goal in an early- to mid-stage trialIn a 32-patient study group that enrolled ambulant and non-ambulant males, t...Reuters
Mon, Dec 8
US STOCKS-U.S. stocks mixed as traders await Fed rate decision, Warner Bros jumps
Indexes: Dow down 0.26%, S&P 500 up 0.01%, Nasdaq up 0.31%Paramount Skydance launches a hostile bid for Warner BrothersConfluent jumps after report IBM nears $11 bln buyout dealBy Johann M Cherian and Pranav Kashyap Dec 8 (Reuters) - Wall Street's main indexes were mixed on Monday as ...Reuters
Mon, Dec 8
Canada's Transcontinental to sell its packaging unit in $1.61 billion deal
Dec 8 (Reuters) - Transcontinental TCLa.TO said on Monday it would sell its packaging unit to ProAmpac Holdings in a C$2.22 billion ($1.61 billion) deal, including debt, sending the Canadian firm's shares up 28%.The sale comes at a time when the packaging industry is grappling with high freight ...Reuters
Mon, Dec 8
Fulcrum Therapeutics jumps after trial data of blood disorder drug
Shares of drug developer Fulcrum Therapeutics FULC.O jump as much as 57.3% to over a three-year high of $14Stock is set for its best day ever in four years, if gains holdFlucrum said on Sunday its experimental drug showed positive results in patients with sickle cell disease from an ongoing 20 dose ...Reuters
Mon, Dec 8
Global equity funds draw inflows ahead of Fed decision
Dec 8 (Reuters) - Global equity funds attracted significant inflows in the week through December 3 as expectations of a potential Federal Reserve rate cut this week boosted risk sentiment.Investors bought global equity funds worth a net $7.93 billion during the week in a reversal from approximately ...Reuters
Mon, Dec 8
PRECIOUS-Gold gains on Fed rate cut bets ahead of FOMC meeting
Fed to decide on rate cut at two-day meetingUkraine's Zelenskiy to meet European leaders in LondonMarkets price in 90% chance of Dec rate cutBy Sarah Qureshi and Arunima Kumar Dec 8 (Reuters) - Gold edged higher on Monday as investors grew more confident that the U.S. Federal Reserve will cut...Reuters
Mon, Dec 8
Market Movers | Wave Life Sciences Rockets 100%; Kymera Therapeutics Soars 48%; Carvana, DXYZ Jump 8% Each; CoreWeave Falls 5%
Wave Life Sciences shares jumped over 100% on Monday after it said it received encouraging preliminary trial data for its investigational weight loss drug WVE-007. The clinical-stage biotechnology company said that it has seen positive interim data from the lowest therapeutic cohort of the continuin...Tiger News
Mon, Dec 8
Canada's Transcontinental surges on $1.61-billion packaging unit sale
Shares of Canadian packaging firm Transcontinental TCLa.TO jumps 20% to about C$24 in morning tradingCo says it has entered into an agreement to sell its packaging unit to ProAmpac Holdings, valuing it C$2.22 bln ($1.61 bln), including debtTranscontinental will distribute C$20 per share in cash to i...Reuters
Mon, Dec 8
LIVE MARKETS-Fed head: Stocks mixed in opening minutes, tech out front
Stocks mixed; Nasdaq out front, S&P 500 ~flat; Dow dipsTech biggest gainer among S&P sectors; Utilties down mostSTOXX 600 ~unchangedDollar inches higher; gold, crude slip; bitcoin upU.S. 10-year Treasury yields rise to 4.18%Welcome to the home for real-time coverage of markets brought to you...Reuters
Mon, Dec 8
Structure Therapeutics surges after weight-loss drug succeeds mid-stage trial
Shares of Structure Therapeutics GPCR.O rise 82% to $63.04GPCR's experimental drug aleniglipron at a dosage of 120 mg showed an 11.3% reduction in weight in a mid-stage study, a figure that was statistically significant compared to placebo at 36 weeks The company plans to initiate a late-stage t...Reuters
Mon, Dec 8
Boeing completes acquisition of Spirit AeroSystems, shares rise
Shares of Boeing BA.N rise nearly 1.7% to about $205.3 in morning trading Boeing closes $4.7 billion takeover of Spirit AeroSystems SPR.N reacquiring the bulk of the world's largest independent wing and fuselage maker Under the deal, 15,000 Spirit AeroSystems employees become part of Boe...Reuters
Mon, Dec 8
Netflix slips as Paramount makes hostile bid for Warner Bros
Streaming giant Netflix's NFLX.O shares fall 2.9% to $97.31Paramount Skydance PSKY.O makes hostile bid for Warner Bros Discovery WBD.O in deal valued at $108.4 bln, including debt, with the equity offer at $30 per shareLast week, NFLX agreed to buy WBD's TV, film studios and streaming assets...Reuters
Mon, Dec 8
U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures were marginally higher on Monday, as investors priced in that the Federal Reserve will deliver a long-awaited rate cut later this week in a meeting that is shaping u...Reuters
Mon, Dec 8
CANADA STOCKS-TSX muted at open as investors brace for central bank decisions
Dec 8 (Reuters) - Canada's main stock index was subdued on Monday, with investors taking a breather ahead of crucial monetary policy decisions in the U.S. and Canada later this week. At 9:30 a.m. ET (1330 GMT), Toronto's S&P/TSX composite index .GSPTSE was down flat at 31,311.33 points.Reuters
Mon, Dec 8
US STOCKS SNAPSHOT-U.S. stocks open higher as investors await Fed rate cut decision
Dec 8 (Reuters) - Wall Street's main indexes opened modestly higher on Monday as investors priced in expectations that the Federal Reserve will deliver a long-awaited rate cut later this week in a meeting that is shaping up to be one of the most divisive in years.The Dow Jones Industrial Average...Reuters
Mon, Dec 8
